Asset Advisors Corp’s Pfizer PFE Stock Holding History

Asset Advisors Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.49M	Sell	72,440 -5,472	-7%	-$187K	0.43%	51
2018 Q1	$2.62M	Sell	77,912 -1,155	-1%	-$39.7K	0.44%	51
2017 Q4	$2.72M	Sell	79,067 -738	-0.9%	-$25.2K	0.44%	52
2017 Q3	$2.7M	Sell	79,805 -7,272	-8%	-$234K	0.48%	51
2017 Q2	$2.77M	Sell	87,077 -5,218	-6%	-$165K	0.5%	50
2017 Q1	$3M	Buy	92,295 +635	+0.7%	+$20K	0.55%	48
2016 Q4	$2.83M	Sell	91,660 -5,397	-6%	-$165K	0.56%	49
2016 Q3	$3.12M	Buy	97,057 +925	+1%	+$30.9K	0.65%	45
2016 Q2	$3.21M	Sell	96,132 -316	-0.3%	-$10.1K	0.67%	42
2016 Q1	$2.71M	Buy	96,448 +1,644	+2%	+$47K	0.59%	45
2015 Q4	$2.9M	Buy	94,804 +209	+0.2%	+$6.58K	0.65%	45
2015 Q3	$2.82M	Buy	94,595 +3,018	+3%	+$96.8K	0.69%	45
2015 Q2	$2.91M	Buy	91,577 +843	+0.9%	+$27.5K	0.65%	47
2015 Q1	$3M	Sell	90,734 -1,054	-1%	-$33.5K	0.67%	44
2014 Q4	$2.71M	Sell	91,788 -3,689	-4%	-$106K	0.6%	46
2014 Q3	$2.68M	Buy	95,477 +106	+0.1%	+$2.98K	0.61%	47
2014 Q2	$2.69M	Sell	95,371 -3,162	-3%	-$90.1K	0.61%	48
2014 Q1	$3M	Sell	98,533 -1,581	-2%	-$47.1K	0.71%	44
2013 Q4	$2.91M	Hold	100,114	–	–	0.7%	46
2013 Q3	$2.73M	Buy	100,114 +527	+0.5%	+$14.3K	0.78%	41
2013 Q2	$2.65M	Buy	+99,587	New	+$2.75M	0.78%	42

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Asset Advisors Corp's PFE Position: Q2 2018 in Review

Asset Advisors Corp reduced its Pfizer (PFE) stake by 7% in Q2 2018, selling an estimated $187K and leaving 72,440 shares worth $2.49M. The position accounts for 0.43% of the portfolio, ranked #51.

Asset Advisors Corp first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. The position peaked at $3.21M in Q2 2016. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Asset Advisors Corp held 72,440 shares of Pfizer worth $2.49M as of Q2 2018.
Asset Advisors Corp sold 5,472 Pfizer shares in Q2 2018, an estimated $187K.
Pfizer made up 0.43% of Asset Advisors Corp's portfolio in Q2 2018, its #51 holding.
Asset Advisors Corp first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
Asset Advisors Corp's Pfizer position peaked at $3.21M in Q2 2016.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Asset Advisors Corp's 13F filing for Q2 2018, filed 20 Jul 2018.